An application made for this job — a tailored resume and cover letter that speak straight to the posting.
Nova In Silico is a health tech company in Lyon that develops an in silico clinical trial platform jinkō to simulate drug efficacy and optimize development. The internship provides significant responsibilities and a steep learning curve within a highly motivated team.
You will work on stochastic gradient estimation for QSP surrogate models, review literature, prototype algorithms, and help integrate solutions into Nova's simulation platform.
Nova In Silico is a health tech company that develops an in silico clinical trial platform jinkō to simulate drug efficacy and optimize clinical development using virtual patients and disease modeling. As an innovative company, we offer a dynamic work environment distinct from larger, established organizations. Interns will gain significant responsibilities and benefit from a steep learning curve, supported by a highly motivated team.
Expectation Maximization, Gradient Descent, Non-Linear Mixed-Effects Model, Surrogate Model, PyTorch
Quantitative Systems Pharmacology (QSP) is a critical discipline in modern drug development. It involves creating complex, mechanistic mathematical models that describe the dynamic interactions between a drug and a biological system. These models integrate pathophysiology and pharmacology to predict a drug's effect, safety, and efficacy across diverse patient populations. At Nova In Silico, our R&D efforts are focused on building and applying these high-fidelity QSP models.
A significant challenge arises when fitting these models to real-world clinical data. To account for variability between individuals, QSP models are often formulated as Non-Linear Mixed-Effects (NLME) models. Parameter estimation for NLME models, which is typically performed via Maximum Likelihood Estimation (MLE), is a difficult and computationally intensive task. Traditional estimation algorithms can take hours or even days to converge, creating a substantial bottleneck in the R&D pipeline.
To address this computational bottleneck, Nova In Silico has successfully developed surrogate models for some of our key QSP models. These surrogates, built using the PyTorch deep learning framework, are lightweight, fast-to-execute approximations of the full, complex QSP models. They are designed to capture the essential input-output behavior of the original model while dramatically reducing computation time.
This speed-up has enabled us to more efficiently perform parameter estimation. Currently, we leverage our surrogate models within Expectation-Maximization (EM) type algorithms. EM is a powerful and standard method for finding maximum likelihood estimates in models with latent variables (such as the random effects in NLME models). This approach has proven effective for our existing model structures.
While effective, EM-type algorithms are often tailored to specific model structures and statistical assumptions. As our R&D pipeline evolves, we aim to explore more diverse and complex surrogate model architectures and apply them to various types of clinical data. The mathematical framework of EM can be restrictive in these more general cases.
Stochastic Gradient Descent (SGD) offers a compelling and flexible alternative, as these algorithms:
The intern will implement the stochastic approximation gradient algorithm, drawing from the principles in the reference articles, and apply it to our existing surrogate models. This will equip Nova In Silico with a novel, flexible, and powerful estimation tool, expanding our capabilities to fit next-generation QSP models to complex clinical data.
We are looking for people who know some of the following or are eager to learn and work with them:
A professional English level (written and oral) is required for this role.